Works matching IS 2574173X AND DT 2021 AND VI 41 AND IP 3

Results: 18

Transient glyphosate encephalopathy due to a suicide attempt.
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 444, doi. 10.1002/npr2.12201
By:
- Yokoyama, Saaya;
- Sugisaki, Tomomi;
- Ryota, Yoshida;
- Yoshiteru, Sato;
- Okayasu, Hiroaki;
- Shioda, Mukuto;
- Suzuki, Keisuke;
- Yasui‐Furukori, Norio;
- Shimoda, Kazutaka
Publication type:
Article
Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report.
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 440, doi. 10.1002/npr2.12200
By:
- Sakai, Shintaro;
- Morimoto, Yoshiro;
- Matsuzaka, Yusuke;
- Nakano, Takeshi;
- Kanegae, Shinji;
- Imamura, Akira;
- Ozawa, Hiroki
Publication type:
Article
The dopamine D2 agonist quinpirole impairs frontal mismatch responses to sound frequency deviations in freely moving rats.
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 405, doi. 10.1002/npr2.12199
By:
- Inaba, Hiroyoshi;
- Namba, Hisaaki;
- Kida, Satoshi;
- Nawa, Hiroyuki
Publication type:
Article
Resolvin D2 attenuates chronic pain–induced depression‐like behavior in mice.
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 426, doi. 10.1002/npr2.12198
By:
- Suzuki, Hiroe;
- Hitora‐Imamura, Natsuko;
- Deyama, Satoshi;
- Minami, Masabumi
Publication type:
Article
Contributions of HFE polymorphisms to brain and blood iron load, and their links to cognitive and motor function in healthy adults.
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 393, doi. 10.1002/npr2.12197
By:
- Kalpouzos, Grégoria;
- Mangialasche, Francesca;
- Falahati, Farshad;
- Laukka, Erika J;
- Papenberg, Goran
Publication type:
Article
Neuropharmacology of Antiseizure Drugs.
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 336, doi. 10.1002/npr2.12196
Publication type:
Article
Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 434, doi. 10.1002/npr2.12195
By:
- Ishikawa, Hayahito;
- Takeshima, Masahiro;
- Ishikawa, Hiroyasu;
- Ayabe, Naoko;
- Ohta, Hidenobu;
- Mishima, Kazuo
Publication type:
Article
SSRIs: Applications in inflammatory lung disease and implications for COVID‐19.
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 325, doi. 10.1002/npr2.12194
By:
- Meikle, Claire Kyung Sun;
- Creeden, Justin Fortune;
- McCullumsmith, Cheryl;
- Worth, Randall G.
Publication type:
Article
Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 266, doi. 10.1002/npr2.12193
Publication type:
Article
Outcomes of patients with schizophrenia who discontinued long‐acting injectable antipsychotic therapy due to adverse events: A chart review.
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 422, doi. 10.1002/npr2.12192
By:
- Kishi, Taro;
- Sakuma, Kenji;
- Okuya, Makoto;
- Hatano, Masakazu;
- Iwata, Nakao
Publication type:
Article
Medications for attention‐deficit/hyperactivity disorder in Japan: A retrospective cohort study of label compliance.
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 385, doi. 10.1002/npr2.12191
By:
- Fife, Daniel;
- Voss, Erica A.;
- Hardin, Jill;
- Rofael, Hany;
- Solomon, Ira D.;
- Ryan, Patrick B.;
- Stang, Paul
Publication type:
Article
Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels.
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 379, doi. 10.1002/npr2.12190
By:
- Tasaki, Minami;
- Yasui‐Furukori, Norio;
- Yokoyama, Saaya;
- Shinozaki, Masataka;
- Sugawara, Norio;
- Shimoda, Kazutaka
Publication type:
Article
Pulverizing medication as a harm reduction and intentional drug overdose prevention strategy: Two case studies.
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 430, doi. 10.1002/npr2.12189
By:
- Takanobu, Keisuke;
- Okazaki, Daisuke;
- Watanabe, Shinya;
- Mitsui, Nobuyuki;
- Tanaka, Teruaki
Publication type:
Article
Effects of extended abstinence on cognitive functions in tramadol‐dependent patients: A cohort study.
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 371, doi. 10.1002/npr2.12188
By:
- Hassaan, Shehab H.;
- Khalifa, Hossam;
- Darwish, Alaa M.
Publication type:
Article
An initial analysis of the UK Medical Cannabis Registry: Outcomes analysis of first 129 patients.
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 362, doi. 10.1002/npr2.12183
By:
- Erridge, Simon;
- Salazar, Oliver;
- Kawka, Michal;
- Holvey, Carl;
- Coomber, Ross;
- Usmani, Azfer;
- Sajad, Mohammed;
- Beri, Sushil;
- Hoare, Jonathan;
- Khan, Shaheen;
- Weatherall, Mark W.;
- Platt, Michael;
- Rucker, James J.;
- Sodergren, Mikael H.
Publication type:
Article
Factors associated with the level of prolactin in patients under remission from Alcohol Use Disorder: A gender perspective.
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 352, doi. 10.1002/npr2.12182
By:
- Pandey, Susmita;
- Bolstad, Ingeborg;
- Lien, Lars;
- Bramness, Jørgen G.
Publication type:
Article
Inter‐breeder differences in prepulse inhibition deficits of C57BL/6J mice in a maternal immune activation model.
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 416, doi. 10.1002/npr2.12178
By:
- Kobayashi, Yutaro;
- Inaba, Hiroyoshi;
- Iwakura, Yuriko;
- Namba, Hisaaki;
- Sotoyama, Hidekazu;
- Murata, Yui;
- Iwamoto, Kazuya;
- Nawa, Hiroyuki
Publication type:
Article
Issue Information.
Published in:
Neuropsychopharmacology Reports, 2021, v. 41, n. 3, p. 265, doi. 10.1002/npr2.12115
Publication type:
Article